Repeatability and reproducibility of cardiac manganese-enhanced magnetic resonance imaging

T Singh1,2,3, S Joshi4,5,6, M N Meah4,5,6

  • 1BHF/University Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK. tsingh@ed.ac.uk.

Scientific Reports
|February 27, 2023
PubMed

Insights

Manganese-enhanced MRI shows excellent repeatability and reproducibility for assessing myocardial calcium handling in healthy hearts. This imaging technique demonstrates high repeatability in diseased hearts, though further research is needed for diffuse fibrosis.

Area of Science:

  • Cardiovascular Imaging
  • Magnetic Resonance Imaging
  • Myocardial Physiology

Background:

  • Manganese-enhanced magnetic resonance imaging (MEMRI) offers a potential method to evaluate myocardial calcium handling.
  • The repeatability and reproducibility of MEMRI have not been previously established.

Purpose of the Study:

  • To assess the intra- and inter-observer repeatability and scan-rescan reproducibility of MEMRI for myocardial calcium handling.
  • To evaluate the repeatability of MEMRI in healthy volunteers and patients with various cardiomyopathies.

Main Methods:

  • Sixty-eight participants (20 healthy, 20 acute myocardial infarction, 18 hypertrophic cardiomyopathy, 10 dilated cardiomyopathy) underwent MEMRI.
  • Native T1 values and myocardial manganese uptake were measured for repeatability.
  • Ten healthy volunteers were rescanned after 3 months to assess scan-rescan reproducibility.

Main Results:

  • Excellent intra-observer and inter-observer repeatability for native T1 mapping and myocardial manganese uptake in healthy volunteers (LCC > 0.96).
  • Excellent scan-rescan reproducibility was observed in healthy volunteers.
  • High intra-observer repeatability was found across all patient groups, including acute myocardial infarction, hypertrophic, and dilated cardiomyopathy.

Conclusions:

  • MEMRI demonstrates high repeatability and reproducibility in healthy myocardium.
  • MEMRI exhibits high repeatability in diseased myocardium, supporting its clinical utility.
  • Further investigation is required to confirm MEMRI's robustness in conditions with diffuse myocardial fibrosis.